BioCentury | Dec 13, 2010
Company News

Hegln Pharmaceutical Co. Ltd., Urodynamix deal

...Urodynamix and the University of British Columbia (Vancouver, B.C.) mutually terminated a license deal, and Urodynamix...
...terms were not disclosed (see BioCentury, July 19). Hegln Pharmaceutical Co. Ltd. , Dalian, China Urodynamix Technologies Ltd....
BioCentury | Jul 19, 2010
Company News

Hegln Pharmaceutical Co. Ltd., Urodynamix deal

...the majority of its assets to Hegln for C$2.1 million ($2 million). The deal includes Urodynamix's...
...British Columbia, the National Research Council of Canada and Urodynamix shareholders. At Dec. 31, 2009, Urodynamix...
...12-month operating loss of C$3 million ($2.8 million). Hegln Pharmaceutical Co. Ltd. , Dalian, China Urodynamix Technologies Ltd....
BioCentury | Sep 21, 2009
Financial News

Urodynamix completes private placement

Urodynamix Technologies Ltd. (TSX-V:URO), Vancouver, B.C. Business: Diagnostic Date completed: 9/11/09 Type: Private placement Raised: C$1.5 million (US$1.4 million) Shares: 30 million Price: C$0.05 Shares after offering: 137.4 million Investors: BC Advantage Funds; and other...
Items per page:
1 - 3 of 3
BioCentury | Dec 13, 2010
Company News

Hegln Pharmaceutical Co. Ltd., Urodynamix deal

...Urodynamix and the University of British Columbia (Vancouver, B.C.) mutually terminated a license deal, and Urodynamix...
...terms were not disclosed (see BioCentury, July 19). Hegln Pharmaceutical Co. Ltd. , Dalian, China Urodynamix Technologies Ltd....
BioCentury | Jul 19, 2010
Company News

Hegln Pharmaceutical Co. Ltd., Urodynamix deal

...the majority of its assets to Hegln for C$2.1 million ($2 million). The deal includes Urodynamix's...
...British Columbia, the National Research Council of Canada and Urodynamix shareholders. At Dec. 31, 2009, Urodynamix...
...12-month operating loss of C$3 million ($2.8 million). Hegln Pharmaceutical Co. Ltd. , Dalian, China Urodynamix Technologies Ltd....
BioCentury | Sep 21, 2009
Financial News

Urodynamix completes private placement

Urodynamix Technologies Ltd. (TSX-V:URO), Vancouver, B.C. Business: Diagnostic Date completed: 9/11/09 Type: Private placement Raised: C$1.5 million (US$1.4 million) Shares: 30 million Price: C$0.05 Shares after offering: 137.4 million Investors: BC Advantage Funds; and other...
Items per page:
1 - 3 of 3